Payment overview · 2025
General Payments
$29.88
1 reported records · 1 companies
Healthcare provider profile · identity verified
Katelin Michele Haley, D.O
Allopathic & Osteopathic Physicians|Family Medicine · LEWES, DE · NPI 1912256512
Verified facts
What the public records show
CMS Open Payments records show Katelin Michele Haley, D.O received $29.88 in general payments during 2025 across 1 reported records.
BeOne Medicines USA, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| BeOne Medicines USA, Inc. | Unresolved — no canonical attribution shown | $29.88 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $29.88 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| BRUKINSA Normalized: brukinsa |
Drug | BeOne Medicines USA, Inc. | $29.88 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 757 | 215 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 663 | 187 |
| Amlodipine Besylate | Amlodipine Besylate | 621 | 173 |
| Levothyroxine Sodium | Levothyroxine Sodium | 511 | 129 |
| Omeprazole | Omeprazole | 428 | 115 |
| Lisinopril | Lisinopril | 389 | 109 |
| Gabapentin | Gabapentin | 334 | 84 |
| Losartan Potassium | Losartan Potassium | 332 | 92 |
| Metoprolol Succinate | Metoprolol Succinate | 309 | 82 |
| Hydrochlorothiazide | Hydrochlorothiazide | 233 | 68 |
| Metformin Hcl | Metformin Hcl | 229 | 69 |
| Famotidine | Famotidine | 209 | 65 |
| Tamsulosin Hcl | Tamsulosin Hcl | 202 | 52 |
| Pantoprazole Sodium | Pantoprazole Sodium | 199 | 56 |
| Trazodone Hcl | Trazodone Hcl | 197 | 50 |
| Escitalopram Oxalate | Escitalopram Oxalate | 194 | 43 |
| Sertraline Hcl | Sertraline Hcl | 191 | 53 |
| Simvastatin | Simvastatin | 171 | 50 |
| Fluticasone Propionate | Fluticasone Propionate | 166 | 64 |
| Furosemide | Furosemide | 159 | 48 |
| Metformin Hcl Er | Metformin Hcl | 159 | 48 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 158 | 49 |
| Metoprolol Tartrate | Metoprolol Tartrate | 154 | 38 |
| Bupropion Xl | Bupropion Hcl | 148 | 33 |
| Duloxetine Hcl | Duloxetine Hcl | 142 | 32 |
| Montelukast Sodium | Montelukast Sodium | 133 | 35 |
| Allopurinol | Allopurinol | 126 | 33 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 115 | 36 |
| Pravastatin Sodium | Pravastatin Sodium | 109 | 29 |
| Meloxicam | Meloxicam | 104 | 37 |
| Finasteride | Finasteride | 103 | 30 |
| Alendronate Sodium | Alendronate Sodium | 102 | 31 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 97 | 25 |
| Eliquis | Apixaban | 96 | 28 |
| Valsartan | Valsartan | 96 | 27 |
| Fluoxetine Hcl | Fluoxetine Hcl | 94 | 27 |
| Synthroid | Levothyroxine Sodium | 93 | 26 |
| Carvedilol | Carvedilol | 91 | 30 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 90 | 25 |
| Clopidogrel | Clopidogrel Bisulfate | 82 | 22 |
| Ozempic | Semaglutide | 81 | 17 |
| Chlorthalidone | Chlorthalidone | 80 | 25 |
| Ezetimibe | Ezetimibe | 79 | 22 |
| Potassium Chloride | Potassium Chloride | 78 | 16 |
| Farxiga | Dapagliflozin Propanediol | 77 | 22 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 77 | 24 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 75 | 24 |
| Atenolol | Atenolol | 68 | 20 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 68 | 56 |
| Tramadol Hcl | Tramadol Hcl | 66 | 19 |
| Tizanidine Hcl | Tizanidine Hcl | 63 | 34 |
| Citalopram Hbr | Citalopram Hydrobromide | 62 | 19 |
| Azelastine Hcl | Azelastine Hcl | 61 | 17 |
| Valacyclovir | Valacyclovir Hcl | 61 | 28 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 59 | 32 |
| Bumetanide | Bumetanide | 58 | suppressed |
| Prednisone | Prednisone | 57 | 35 |
| Jardiance | Empagliflozin | 56 | 15 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 56 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 56 | 13 |
| Mounjaro | Tirzepatide | 55 | suppressed |
| Trulicity | Dulaglutide | 53 | 16 |
| Ibuprofen | Ibuprofen | 49 | 14 |
| Lovastatin | Lovastatin | 49 | 11 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 47 | 12 |
| Spironolactone | Spironolactone | 47 | 14 |
| Propranolol Hcl | Propranolol Hcl | 46 | suppressed |
| Irbesartan | Irbesartan | 44 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 44 | suppressed |
| Cephalexin | Cephalexin | 43 | 30 |
| Fenofibrate | Fenofibrate Nanocrystallized | 43 | suppressed |
| Glipizide Er | Glipizide | 43 | 13 |
| Donepezil Hcl | Donepezil Hcl | 42 | suppressed |
| Naproxen | Naproxen | 42 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 41 | suppressed |
| Rybelsus | Semaglutide | 41 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 40 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 39 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 38 | 31 |
| Ramipril | Ramipril | 37 | suppressed |
| Adacel Tdap | Diph,pertuss(Acell),tet Vac/Pf | 36 | 36 |
| Celecoxib | Celecoxib | 36 | suppressed |
| Fenofibrate | Fenofibrate | 36 | suppressed |
| Mirtazapine | Mirtazapine | 36 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 36 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 35 | 24 |
| Myrbetriq | Mirabegron | 35 | 12 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 35 | 11 |
| Meclizine Hcl | Meclizine Hcl | 33 | 18 |
| Januvia | Sitagliptin Phosphate | 32 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 32 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 31 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 30 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 30 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 30 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 30 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 29 | 28 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 29 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 29 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 28 | suppressed |
| Ketoconazole | Ketoconazole | 28 | 12 |
| Pregabalin | Pregabalin | 28 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 28 | suppressed |
| Temazepam | Temazepam | 28 | suppressed |
| Alprazolam | Alprazolam | 27 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 27 | suppressed |
| Xarelto | Rivaroxaban | 27 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 26 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 25 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 25 | suppressed |
| Topiramate | Topiramate | 25 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 24 | suppressed |
| Memantine Hcl | Memantine Hcl | 24 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 24 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 24 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 23 | 11 |
| Buspirone Hcl | Buspirone Hcl | 23 | 13 |
| Terazosin Hcl | Terazosin Hcl | 23 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 22 | suppressed |
| Lansoprazole | Lansoprazole | 22 | suppressed |
| Mupirocin | Mupirocin | 22 | 18 |
| Clonazepam | Clonazepam | 21 | suppressed |
| Lorazepam | Lorazepam | 21 | 16 |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 21 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Colchicine | Colchicine | 20 | suppressed |
| Fluconazole | Fluconazole | 20 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 19 | suppressed |
| Nystatin | Nystatin | 19 | 13 |
| Amoxicillin | Amoxicillin | 18 | 13 |
| Febuxostat | Febuxostat | 18 | suppressed |
| Nifedipine Er | Nifedipine | 18 | suppressed |
| Premarin | Estrogens, Conjugated | 18 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 18 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 17 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 17 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 17 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 17 | suppressed |
| Lamotrigine | Lamotrigine | 17 | suppressed |
| Levetiracetam | Levetiracetam | 17 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 17 | suppressed |
| Dayvigo | Lemborexant | 16 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 16 | suppressed |
| Diazepam | Diazepam | 16 | suppressed |
| Glimepiride | Glimepiride | 16 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 16 | 16 |
| Vascepa | Icosapent Ethyl | 16 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 15 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 15 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 15 | suppressed |
| Azithromycin | Azithromycin | 14 | 13 |
| Bydureon Bcise | Exenatide Microspheres | 14 | suppressed |
| Desloratadine | Desloratadine | 14 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Glipizide | Glipizide | 14 | suppressed |
| Methylprednisolone | Methylprednisolone | 14 | 12 |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 13 | suppressed |
| Baclofen | Baclofen | 13 | suppressed |
| Candesartan-Hydrochlorothiazid | Candesartan/Hydrochlorothiazid | 13 | suppressed |
| Clotrimazole | Clotrimazole | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 13 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 13 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 13 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 13 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | 12 |
| Acyclovir | Acyclovir | 12 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 12 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 12 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 12 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 12 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 12 | suppressed |
| Ondansetron Odt | Ondansetron | 12 | 12 |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 11 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Dutasteride | Dutasteride | 11 | suppressed |
| Eszopiclone | Eszopiclone | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Vyvanse | Lisdexamfetamine Dimesylate | 11 | suppressed |
| Wegovy | Semaglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $29.88 · 1 records | BeOne Medicines USA, Inc. | BRUKINSA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error